Back to results
US 2019/0160014 A1Published application
Stable Solid Pharmaceutical Formulations Containing 2-(2-Nitro-4-Trifluoromethylbenzoyl)-1,3-Cylcohexanedione
AssigneeDipharma S.p.A.
InventorsChiara CONTI, Salvatore Agostino GIAMMILLARI, Giuseppe MACCARI
Life of this patent
Estimating the term…
Abstract
The present invention relates to highly stable drug dosage forms comprising. The invention also contemplates said highly stable drug dosage forms for the treatment of diseases where inhibition of 4-hydroxyphenylpyruvate dioxygenase 5 will result at improving the health of the patient.
Claims11
A stable solid pharmaceutical formulation comprising 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione as a pharmaceutically active ingredient, pregelatinized starch and stearic acid.
11-20. (canceled)
Dependencies are inferred from the claim text.